Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Prospective Observational Cohort Study of the Effectiveness and Safety of Cytokinogenetic Therapy in Patients With Cancer Based on TCTD-1 Patient Registry

NCT06222801 is registered in ClinicalTrials.gov with OncoCareClinic 308 Ltd as lead sponsor.

NCT NCT06222801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06222801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Prospective Observational Cohort Study of the Effectiveness and Safety of Cytokinogenetic Therapy in Patients With Cancer Based on TCTD-1 Patient Registry
Lead sponsor
OncoCareClinic 308 Ltd
Phase
Observational
Overall status
Recruiting
Start date
September 19, 2022
Completion date
December 1, 2032
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oncology